← All companies

Biocartesian
ActiveConverting biology into digital molecular maps
S24·Summer 2024·Healthcare·Philadelphia, PA, USA·Team of 2·Founded 2023
About
Finding new cures requires seeing what and where the abnormal molecules are in a diseased tissue, but current tools see less than 1% of those molecules. Biocartesian combines microscopy and new chemistries to see 50X more, offering unprecedented insights into disease biology and new therapies.
Founders
Ian Dardani· Founder/CEOCo-founder of Biocartesian. Microscopy + molecular tools + engineering. Previously Bioscience Enterprise at Cambridge, Bioengineering PhD at UPenn.
Jess Li· FounderCo-founder of Biocartesian. Genetics + epigenetics, next-gen sequencing. Previously PhD at UPenn, BD at imvaria.
Product launches · 1 launch
We use chemistry and microscopy to help scientists discover new drugs.
Change history · 14 recorded
- August 30, 2026
- Founder profile updated08:00 PM
- Launches refreshed08:00 PM
- August 16, 2026
- Launches refreshed08:01 PM
- Founder profile updated08:01 PM
- July 26, 2026
- Relocated to Philadelphia08:01 PM
- Founder profile updated08:01 PM
- Launches refreshed08:01 PM
- Location updated07:00 PM
- July 12, 2026
- Launches refreshed08:01 PM
- Founder profile updated08:01 PM
- June 28, 2026
- Launches refreshed08:01 PM
- Founder profile updated08:01 PM
- June 14, 2026
- Founder profile updated08:01 PM
- Launches refreshed08:01 PM